Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
4.970
-0.150 (-2.93%)
At close: Oct 9, 2026, 4:00 PM EDT
4.998
+0.028 (0.57%)
After-hours: Oct 9, 2026, 7:37 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $18.96 million as of October 9, 2026. It is the 37,546th most valuable company in the world and the 5,272nd biggest in the United States. Its market cap has increased by 632.03% in one year.
Market Cap
18.96M
Enterprise Value
11.51M
1-Year Change
632.03%
Global Rank
Country Rank
#5,272 United States
Category
ChartMarket Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $18.96M, a decrease of -94.14%. That is a compound annual growth rate of -44.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 18.96M | 1,244.10% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quoin Pharmaceuticals | 21.86M |
| Polyrizon | 21.54M |
| Cocrystal Pharma | 20.42M |
| Jasper Therapeutics | 18.63M |
| Akari Therapeutics, | 18.58M |
| Estrella Immunopharma | 18.16M |
| Neuphoria Therapeutics | 18.13M |
| NewcelX | 17.96M |